← Leaderboards
Camila Dos Santos
Cold Spring Harbor Laboratory
$6,790,320
Attributed
$6,790,320
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,790,320 · 7
By mechanism
R01$5,376,743 · 3
P30$717,806 · 2
P01$695,771 · 2
Top collaborators
No co-investigators on record.
Most similar at Cold Spring Harbor Laboratory
Same institution · by research overlap
- Gregory J Hannon$22,911,444
Others in their field
Other Emerging Leaders on “Molecular”
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Lynn Briscoe · Leidos Biomedical Research, Inc.$137,360,557
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$109,548,439
- Leonard Freedmand · Leidos Biomedical Research, Inc.$85,594,314
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$76,895,673
- Scott Hensley · University Of Pennsylvania$41,662,743
Research focus
MolecularOrganoidsCellsLinkTumorResponsePregnancyMalignant - DescriptorBreastMalignant Breast NeoplasmMalignant NeoplasmsGenetic TranscriptionMammary NeoplasmsOverexpressionC-Myc GenesTumorigenesisBiological ModelsEpigenomicsBreast Epithelial CellsEpigenetic ProcessEpigenomeOncogenesProgramsWoman
Grant awards (21)
Blockade of cMYC oncogenic function by pregnancy-induced alterations and remodeling of the mammary gland$482,133
R01 · FY2025 · CA · contact PI
Core B: Organoid Biobank$241,920
P01 · FY2025 · CA · contact PI
Organoid Shared Resource$142,489
P30 · FY2025 · CA · contact PI
Blockade of cMYC oncogenic function by pregnancy-induced alterations and remodeling of the mammary gland$443,162
R01 · FY2024 · CA · contact PI
Probing the role of epigenomics in Brca1-deficient mammary tumors.$417,241
R01 · FY2024 · CA · contact PI
Defining the cellular and molecular effects of aging and age of pregnancy on breast tissue homeostasis and cancer initiation$357,683
R01 · FY2024 · AG · contact PI
Core B: Organoid Biobank$211,931
P01 · FY2024 · CA · contact PI
Organoid Shared Resource$147,850
P30 · FY2024 · CA · contact PI
Blockade of cMYC oncogenic function by pregnancy-induced alterations and remodeling of the mammary gland$509,988
R01 · FY2023 · CA · contact PI
Probing the role of epigenomics in Brca1-deficient mammary tumors.$430,416
R01 · FY2023 · CA · contact PI
Defining the cellular and molecular effects of aging and age of pregnancy on breast tissue homeostasis and cancer initiation$357,683
R01 · FY2023 · AG · contact PI
Core B: Organoid Biobank$241,920
P01 · FY2023 · CA · contact PI
Organoid Shared Resource$142,489
P30 · FY2023 · CA · contact PI
Probing the role of epigenomics in Brca1-deficient mammary tumors.$430,416
R01 · FY2022 · CA · contact PI
Defining the cellular and molecular effects of aging and age of pregnancy on breast tissue homeostasis and cancer initiation$357,683
R01 · FY2022 · AG · contact PI
Organoid Shared Resource$142,489
P30 · FY2022 · CA · contact PI
Probing the role of epigenomics in Brca1-deficient mammary tumors.$439,200
R01 · FY2021 · CA · contact PI
Defining the cellular and molecular effects of aging and age of pregnancy on breast tissue homeostasis and cancer initiation$357,683
R01 · FY2021 · AG · contact PI
Organoid Shared Resource$142,489
P30 · FY2021 · CA · contact PI
Probing the role of epigenomics in Brca1-deficient mammary tumors.$439,200
R01 · FY2020 · CA · contact PI
Defining the cellular and molecular effects of aging and age of pregnancy on breast tissue homeostasis and cancer initiation$354,255
R01 · FY2020 · AG · contact PI